Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting

Katherine Francis, Val Gebski, Sarah Lord, Michael Friedlander, Eric Pujade-Lauraine, et al.. Reporting the trajectories of adverse events over the entire treatment course in patients with recurrent platinum-sensitive ovarian cancer treated with platinum-based combination chemotherapy regimens: A graphical approach to trial adverse event reporting. European Journal of Cancer, Elsevier, 2021, 148, pp.251-259. ⟨10.1016/j.ejca.2021.02.006⟩. ⟨hal-03236358⟩